PRAX
insider transactionsPraxis Precision Medicines, Inc. — buys & sells by directors, officers and 10% owners A shareholder owning more than 10% of the company. Must report trades, but usually a weaker signal than an officer or director. (SEC Form 4).
No open-market buys or sells this period. The trades below are grants, option exercises and gifts, which carry no market price.
Net buy / sell volume
Not enough data to chart yet.
Tap or hover the chart for daily net volume. Green = net buying, red = net selling.
All transactions
-
Grant·A
Director
$0
13.4K sh
Own New
-
Grant·A
Director
$0
6.0K sh
Own +7%
-
Grant·A
Director
$0
648 sh
Own New
-
Grant·A
Director
$0
1.4K sh
Own +72%
-
Grant·A
Director
$0
648 sh
Own New
-
Grant·A
Director
$0
1.4K sh
Own +8%
-
Grant·A
Director
$0
648 sh
Own New
-
Grant·A
Director
$0
1.4K sh
Own +118%
-
Grant·A
Director
$0
648 sh
Own New
-
Grant·A
Director
$0
1.4K sh
Own +142%
-
Grant·A
Director
$0
648 sh
Own New
-
Grant·A
Director
$0
1.4K sh
Own New
-
Grant·A
Director
$0
648 sh
Own New
-
Grant·A
Director
$0
1.4K sh
Own New
-
Grant·A
Director
$0
648 sh
Own New
-
Grant·A
Director
$0
1.4K sh
Own +118%
| Date▾ | Insider | Type | Shares | Value |
|---|---|---|---|---|
| Jun 12, 2026 | Dean J Mitchell | Grant A | 13.4K | $0 |
| Jun 12, 2026 | Dean J Mitchell | Grant A | 6.0K | $0 |
| Jun 10, 2026 | William D Young | Grant A | 648 | $0 |
| Jun 10, 2026 | William D Young | Grant A | 1.4K | $0 |
| Jun 10, 2026 | Dean J Mitchell | Grant A | 648 | $0 |
| Jun 10, 2026 | Dean J Mitchell | Grant A | 1.4K | $0 |
| Jun 10, 2026 | Jeffrey B Kindler | Grant A | 648 | $0 |
| Jun 10, 2026 | Jeffrey B Kindler | Grant A | 1.4K | $0 |
| Jun 10, 2026 | Jill Desimone | Grant A | 648 | $0 |
| Jun 10, 2026 | Jill Desimone | Grant A | 1.4K | $0 |
| Jun 10, 2026 | Merit Ester Cudkowicz | Grant A | 648 | $0 |
| Jun 10, 2026 | Merit Ester Cudkowicz | Grant A | 1.4K | $0 |
| Jun 10, 2026 | Jeffrey Chodakewitz | Grant A | 648 | $0 |
| Jun 10, 2026 | Jeffrey Chodakewitz | Grant A | 1.4K | $0 |
| Jun 10, 2026 | Stuart A Arbuckle | Grant A | 648 | $0 |
| Jun 10, 2026 | Stuart A Arbuckle | Grant A | 1.4K | $0 |
About PRAX insider trading
This page tracks insider transactions for Praxis Precision Medicines, Inc. (PRAX) reported to the U.S. Securities and Exchange Commission on Form 4. Corporate insiders — directors, executive officers and beneficial owners of more than 10% of the stock — must disclose their trades within two business days. Open-market purchases (code P) and sales (code S) made at the insider's discretion are the most-watched opportunistic signals, while awards (A), option exercises (M) and tax-withholding (F) reflect compensation rather than conviction. Trades marked 10b5-1 were made under a pre-arranged plan and are considered routine. A cluster buy — several insiders buying within a short window — is historically a stronger bullish indicator than any single trade.